Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 37 entries
Sorted by: Best Match Show Resources per page
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group.

Circulation

Collins GS, Reitsma JB, Altman DG, Moons KG.
PMID: 25561516
Circulation. 2015 Jan 13;131(2):211-9. doi: 10.1161/CIRCULATIONAHA.114.014508. Epub 2015 Jan 05.

BACKGROUND: Prediction models are developed to aid health care providers in estimating the probability or risk that a specific disease or condition is present (diagnostic models) or that a specific event will occur in the future (prognostic models), to...

Cite
Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group. Circulation. 2015;131(2):211-9doi: 10.1161/CIRCULATIONAHA.114.014508.
Collins, G. S., Reitsma, J. B., Altman, D. G., Moons, K. G. (2015). Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group. Circulation, 131(2), 211-9. https://doi.org/10.1161/CIRCULATIONAHA.114.014508
Collins, Gary S, et al. "Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group." Circulation vol. 131,2 (2015): 211-9. doi: https://doi.org/10.1161/CIRCULATIONAHA.114.014508
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group. Circulation. 2015 Jan 13;131(2):211-9. doi: 10.1161/CIRCULATIONAHA.114.014508. Epub 2015 Jan 05. PMID: 25561516; PMCID: PMC4297220.
Copy Download .nbib Format: NLM
Risk factors for emergency presentation with lung and colorectal cancers: a systematic review.

BMJ open

Mitchell ED, Pickwell-Smith B, Macleod U.
PMID: 25838506
BMJ Open. 2015 Apr 02;5(4):e006965. doi: 10.1136/bmjopen-2014-006965.

OBJECTIVE: To identify patient and practitioner factors that influence cancer diagnosis via emergency presentation (EP).DESIGN: Systematic review.DATA SOURCES: MEDLINE, EMBASE, CINAHL, EBM Reviews, Science and Social Sciences Citation Indexes, Conference Proceedings Citation Index-Science and Conference Proceedings Citation Index-Social Science...

Cite
Mitchell ED, Pickwell-Smith B, Macleod U. Risk factors for emergency presentation with lung and colorectal cancers: a systematic review. BMJ Open. 2015;5(4):e006965doi: 10.1136/bmjopen-2014-006965.
Mitchell, E. D., Pickwell-Smith, B., & Macleod, U. (2015). Risk factors for emergency presentation with lung and colorectal cancers: a systematic review. BMJ open, 5(4), e006965. https://doi.org/10.1136/bmjopen-2014-006965
Mitchell, Elizabeth D, et al. "Risk factors for emergency presentation with lung and colorectal cancers: a systematic review." BMJ open vol. 5,4 (2015): e006965. doi: https://doi.org/10.1136/bmjopen-2014-006965
Mitchell ED, Pickwell-Smith B, Macleod U. Risk factors for emergency presentation with lung and colorectal cancers: a systematic review. BMJ Open. 2015 Apr 02;5(4):e006965. doi: 10.1136/bmjopen-2014-006965. PMID: 25838506; PMCID: PMC4390717.
Copy Download .nbib Format: NLM
High on-off conductance switching ratio in optically-driven self-assembled conjugated molecular systems.

ACS nano

Smaali K, Lenfant S, Karpe S, Oçafrain M, Blanchard P, Deresmes D, Godey S, Rochefort A, Roncali J, Vuillaume D.
PMID: 20349942
ACS Nano. 2010 Apr 27;4(4):2411-21. doi: 10.1021/nn100295x.

A new azobenzene-thiophene molecular switch is designed, synthesized, and used to form self-assembled monolayers (SAM) on gold. An "on/off" conductance ratio up to 7 x 10(3) (with an average value of 1.5 x 10(3)) is reported. The "on" conductance...

Cite
Smaali K, Lenfant S, Karpe S, et al. High on-off conductance switching ratio in optically-driven self-assembled conjugated molecular systems. ACS Nano. 2010;4(4):2411-21doi: 10.1021/nn100295x.
Smaali, K., Lenfant, S., Karpe, S., Oçafrain, M., Blanchard, P., Deresmes, D., Godey, S., Rochefort, A., Roncali, J., & Vuillaume, D. (2010). High on-off conductance switching ratio in optically-driven self-assembled conjugated molecular systems. ACS nano, 4(4), 2411-21. https://doi.org/10.1021/nn100295x
Smaali, Kacem, et al. "High on-off conductance switching ratio in optically-driven self-assembled conjugated molecular systems." ACS nano vol. 4,4 (2010): 2411-21. doi: https://doi.org/10.1021/nn100295x
Smaali K, Lenfant S, Karpe S, Oçafrain M, Blanchard P, Deresmes D, Godey S, Rochefort A, Roncali J, Vuillaume D. High on-off conductance switching ratio in optically-driven self-assembled conjugated molecular systems. ACS Nano. 2010 Apr 27;4(4):2411-21. doi: 10.1021/nn100295x. PMID: 20349942.
Copy Download .nbib Format: NLM
Identification and correction of previously unreported spatial phenomena using raw Illumina BeadArray data.

BMC bioinformatics

Smith ML, Dunning MJ, Tavaré S, Lynch AG.
PMID: 20423502
BMC Bioinformatics. 2010 Apr 27;11:208. doi: 10.1186/1471-2105-11-208.

BACKGROUND: A key stage for all microarray analyses is the extraction of feature-intensities from an image. If this step goes wrong, then subsequent preprocessing and processing stages will stand little chance of rectifying the matter. Illumina employ random construction...

Cite
Smith ML, Dunning MJ, Tavaré S, et al. Identification and correction of previously unreported spatial phenomena using raw Illumina BeadArray data. BMC Bioinformatics. 2010;11:208doi: 10.1186/1471-2105-11-208.
Smith, M. L., Dunning, M. J., Tavaré, S., & Lynch, A. G. (2010). Identification and correction of previously unreported spatial phenomena using raw Illumina BeadArray data. BMC bioinformatics, 11208. https://doi.org/10.1186/1471-2105-11-208
Smith, Mike L, et al. "Identification and correction of previously unreported spatial phenomena using raw Illumina BeadArray data." BMC bioinformatics vol. 11 (2010): 208. doi: https://doi.org/10.1186/1471-2105-11-208
Smith ML, Dunning MJ, Tavaré S, Lynch AG. Identification and correction of previously unreported spatial phenomena using raw Illumina BeadArray data. BMC Bioinformatics. 2010 Apr 27;11:208. doi: 10.1186/1471-2105-11-208. PMID: 20423502; PMCID: PMC2880029.
Copy Download .nbib Format: NLM
What is a psychological intervention? A metareview and practical proposal.

Psycho-oncology

Hodges LJ, Walker J, Kleiboer AM, Ramirez AJ, Richardson A, Velikova G, Sharpe M.
PMID: 20878870
Psychooncology. 2011 May;20(5):470-8. doi: 10.1002/pon.1780.

OBJECTIVE: What do we mean by a 'psychological intervention' in the context of cancer care? It is critical to know what treatments are included under this term, if data from diverse treatment trials are to be summarized in order...

Cite
Hodges LJ, Walker J, Kleiboer AM, et al. What is a psychological intervention? A metareview and practical proposal. Psychooncology. 2011;20(5):470-8doi: 10.1002/pon.1780.
Hodges, L. J., Walker, J., Kleiboer, A. M., Ramirez, A. J., Richardson, A., Velikova, G., & Sharpe, M. (2011). What is a psychological intervention? A metareview and practical proposal. Psycho-oncology, 20(5), 470-8. https://doi.org/10.1002/pon.1780
Hodges, Laura J, et al. "What is a psychological intervention? A metareview and practical proposal." Psycho-oncology vol. 20,5 (2011): 470-8. doi: https://doi.org/10.1002/pon.1780
Hodges LJ, Walker J, Kleiboer AM, Ramirez AJ, Richardson A, Velikova G, Sharpe M. What is a psychological intervention? A metareview and practical proposal. Psychooncology. 2011 May;20(5):470-8. doi: 10.1002/pon.1780. PMID: 20878870.
Copy Download .nbib Format: NLM
Partners in death: a role for p73 and NF-kB in promoting apoptosis.

Aging

Vousden KH.
PMID: 20157515
Aging (Albany NY). 2009 Mar 28;1(3):275-7. doi: 10.18632/aging.100033.

No abstract available.

Cite
Vousden KH. Partners in death: a role for p73 and NF-kB in promoting apoptosis. Aging (Albany NY). 2009;1(3):275-7doi: 10.18632/aging.100033.
Vousden, K. H. (2009). Partners in death: a role for p73 and NF-kB in promoting apoptosis. Aging, 1(3), 275-7. https://doi.org/10.18632/aging.100033
Vousden, Karen H. "Partners in death: a role for p73 and NF-kB in promoting apoptosis." Aging vol. 1,3 (2009): 275-7. doi: https://doi.org/10.18632/aging.100033
Vousden KH. Partners in death: a role for p73 and NF-kB in promoting apoptosis. Aging (Albany NY). 2009 Mar 28;1(3):275-7. doi: 10.18632/aging.100033. PMID: 20157515; PMCID: PMC2806010.
Copy Download .nbib Format: NLM
Effective adoptive T-cell therapy for cancer in the absence of host lymphodepletion.

Immunotherapy

Gilham DE.
PMID: 21322758
Immunotherapy. 2011 Feb;3(2):177-9. doi: 10.2217/imt.10.115.

Evaluation of: Ly LV, Sluijter M, Versluis M et al.: Peptide vaccination after T-cell transfer causes massive clonal expansion, tumor eradication and manageable cytokine storm. Cancer Res. 70(21), 8339-46 (2010). Adoptive T-cell transfer (ACT) to treat cancer, autoimmunity and...

Cite
Gilham DE. Effective adoptive T-cell therapy for cancer in the absence of host lymphodepletion. Immunotherapy. 2011;3(2):177-9doi: 10.2217/imt.10.115.
Gilham, D. E. (2011). Effective adoptive T-cell therapy for cancer in the absence of host lymphodepletion. Immunotherapy, 3(2), 177-9. https://doi.org/10.2217/imt.10.115
Gilham, David E. "Effective adoptive T-cell therapy for cancer in the absence of host lymphodepletion." Immunotherapy vol. 3,2 (2011): 177-9. doi: https://doi.org/10.2217/imt.10.115
Gilham DE. Effective adoptive T-cell therapy for cancer in the absence of host lymphodepletion. Immunotherapy. 2011 Feb;3(2):177-9. doi: 10.2217/imt.10.115. PMID: 21322758.
Copy Download .nbib Format: NLM
Targeting T cells to tumor: exploiting the chimeric antibody receptor.

Immunotherapy

Gilham DE, Cheadle EJ.
PMID: 23998728
Immunotherapy. 2013 Sep;5(9):927-9. doi: 10.2217/imt.13.92.

Adoptive therapy using gene-modified T cells to express chimeric antigen receptors (CARs) is gaining pace in the clinic, particularly in hematological malignancies. Translation into treatment of solid tumors has been slower, not least because of the lack of truly...

Cite
Gilham DE, Cheadle EJ. Targeting T cells to tumor: exploiting the chimeric antibody receptor. Immunotherapy. 2013;5(9):927-9doi: 10.2217/imt.13.92.
Gilham, D. E., & Cheadle, E. J. (2013). Targeting T cells to tumor: exploiting the chimeric antibody receptor. Immunotherapy, 5(9), 927-9. https://doi.org/10.2217/imt.13.92
Gilham, David E, and Cheadle, Eleanor J. "Targeting T cells to tumor: exploiting the chimeric antibody receptor." Immunotherapy vol. 5,9 (2013): 927-9. doi: https://doi.org/10.2217/imt.13.92
Gilham DE, Cheadle EJ. Targeting T cells to tumor: exploiting the chimeric antibody receptor. Immunotherapy. 2013 Sep;5(9):927-9. doi: 10.2217/imt.13.92. PMID: 23998728.
Copy Download .nbib Format: NLM
Cancer evolution: the final frontier of precision medicine?.

Annals of oncology : official journal of the European Society for Medical Oncology

Swanton C.
PMID: 24567514
Ann Oncol. 2014 Mar;25(3):549-551. doi: 10.1093/annonc/mdu005.

No abstract available.

Cite
Swanton C. Cancer evolution: the final frontier of precision medicine?. Ann Oncol. 2014;25(3):549-551doi: 10.1093/annonc/mdu005.
Swanton, C. (2014). Cancer evolution: the final frontier of precision medicine?. Annals of oncology : official journal of the European Society for Medical Oncology, 25(3), 549-551. https://doi.org/10.1093/annonc/mdu005
Swanton, Charles. "Cancer evolution: the final frontier of precision medicine?." Annals of oncology : official journal of the European Society for Medical Oncology vol. 25,3 (2014): 549-551. doi: https://doi.org/10.1093/annonc/mdu005
Swanton C. Cancer evolution: the final frontier of precision medicine?. Ann Oncol. 2014 Mar;25(3):549-551. doi: 10.1093/annonc/mdu005. PMID: 24567514; PMCID: PMC4433531.
Copy Download .nbib Format: NLM
Unprovoked venous thromboembolism: assess for cancer.

The Lancet. Oncology

Shaboodien R, Stansby G, Hunt BJ, Agarwal R.
PMID: 23026822
Lancet Oncol. 2012 Oct;13(10):973-4. doi: 10.1016/S1470-2045(12)70415-1.

No abstract available.

Cite
Shaboodien R, Stansby G, Hunt BJ, et al. Unprovoked venous thromboembolism: assess for cancer. Lancet Oncol. 2012;13(10):973-4doi: 10.1016/S1470-2045(12)70415-1.
Shaboodien, R., Stansby, G., Hunt, B. J., & Agarwal, R. (2012). Unprovoked venous thromboembolism: assess for cancer. The Lancet. Oncology, 13(10), 973-4. https://doi.org/10.1016/S1470-2045(12)70415-1
Shaboodien, Roekshana, et al. "Unprovoked venous thromboembolism: assess for cancer." The Lancet. Oncology vol. 13,10 (2012): 973-4. doi: https://doi.org/10.1016/S1470-2045(12)70415-1
Shaboodien R, Stansby G, Hunt BJ, Agarwal R. Unprovoked venous thromboembolism: assess for cancer. Lancet Oncol. 2012 Oct;13(10):973-4. doi: 10.1016/S1470-2045(12)70415-1. PMID: 23026822.
Copy Download .nbib Format: NLM
Developing agent-based models of complex health behaviour.

Health & place

Badham J, Chattoe-Brown E, Gilbert N, Chalabi Z, Kee F, Hunter RF.
PMID: 30290315
Health Place. 2018 Nov;54:170-177. doi: 10.1016/j.healthplace.2018.08.022. Epub 2018 Oct 02.

Managing non-communicable diseases requires policy makers to adopt a whole systems perspective that adequately represents the complex causal architecture of human behaviour. Agent-based modelling is a computational method to understand the behaviour of complex systems by simulating the actions...

Cite
Badham J, Chattoe-Brown E, Gilbert N, et al. Developing agent-based models of complex health behaviour. Health Place. 2018;54:170-177doi: 10.1016/j.healthplace.2018.08.022.
Badham, J., Chattoe-Brown, E., Gilbert, N., Chalabi, Z., Kee, F., & Hunter, R. F. (2018). Developing agent-based models of complex health behaviour. Health & place, 54170-177. https://doi.org/10.1016/j.healthplace.2018.08.022
Badham, Jennifer, et al. "Developing agent-based models of complex health behaviour." Health & place vol. 54 (2018): 170-177. doi: https://doi.org/10.1016/j.healthplace.2018.08.022
Badham J, Chattoe-Brown E, Gilbert N, Chalabi Z, Kee F, Hunter RF. Developing agent-based models of complex health behaviour. Health Place. 2018 Nov;54:170-177. doi: 10.1016/j.healthplace.2018.08.022. Epub 2018 Oct 02. PMID: 30290315; PMCID: PMC6284360.
Copy Download .nbib Format: NLM
The Aarhus statement: improving design and reporting of studies on early cancer diagnosis.

British journal of cancer

Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, Campbell C, Andersen RS, Hamilton W, Olesen F, Rose P, Nafees S, van Rijswijk E, Hiom S, Muth C, Beyer M, Neal RD.
PMID: 22415239
Br J Cancer. 2012 Mar 27;106(7):1262-7. doi: 10.1038/bjc.2012.68. Epub 2012 Mar 13.

Early diagnosis is a key factor in improving the outcomes of cancer patients. A greater understanding of the pre-diagnostic patient pathways is vital yet, at present, research in this field lacks consistent definitions and methods. As a consequence much...

Cite
Weller D, Vedsted P, Rubin G, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012;106(7):1262-7doi: 10.1038/bjc.2012.68.
Weller, D., Vedsted, P., Rubin, G., Walter, F. M., Emery, J., Scott, S., Campbell, C., Andersen, R. S., Hamilton, W., Olesen, F., Rose, P., Nafees, S., van Rijswijk, E., Hiom, S., Muth, C., Beyer, M., & Neal, R. D. (2012). The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. British journal of cancer, 106(7), 1262-7. https://doi.org/10.1038/bjc.2012.68
Weller, D, et al. "The Aarhus statement: improving design and reporting of studies on early cancer diagnosis." British journal of cancer vol. 106,7 (2012): 1262-7. doi: https://doi.org/10.1038/bjc.2012.68
Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, Campbell C, Andersen RS, Hamilton W, Olesen F, Rose P, Nafees S, van Rijswijk E, Hiom S, Muth C, Beyer M, Neal RD. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012 Mar 27;106(7):1262-7. doi: 10.1038/bjc.2012.68. Epub 2012 Mar 13. PMID: 22415239; PMCID: PMC3314787.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 37 entries